The copper peptide with real cosmetic-science evidence — and a very different story once you inject it
Read the route carefully
GHK-Cu has a legitimate evidence base as a topical cosmetic ingredient. Its use as an injectable is off-label and research-only, with far less evidence and no FDA approval. Anything sold as injectable GHK-Cu is an unregulated research chemical. This page is educational, not medical advice.
Class
Copper tripeptide
Strongest evidence
Topical / skin
Injectable status
Not approved
GHK-Cu is a small copper-binding tripeptide — glycyl-L-histidyl-L-lysine complexed with copper(II). It occurs naturally in human plasma, saliva, and urine, and its level in the body tends to decline with age. Since the foundational work of Loren Pickart in the 1970s onward, it has been studied for roles in wound healing, tissue remodeling, and skin regeneration, which is why it became a mainstay ingredient in cosmetic skincare.
GHK-Cu is a real molecule with a genuinely respectable record — as a topical skincare ingredient. That reputation is often borrowed to sell injectable protocols promising systemic anti-aging benefits, and that leap is exactly where the evidence runs out. If a claim about injected GHK-Cu sounds as settled as the skincare data, that is a marketing move, not a scientific one.
If you're tracking a protocol, do it privately and honestly. Jabbit is an ad-free injection log — no data selling, no hype.
Download on App Store